Английская Википедия:DelNS1-2019-nCoV-RBD-OPT

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Use dmy dates Шаблон:Infobox drug Шаблон:COVID-19 pandemic sidebar DelNS1-2019-nCoV-RBD-OPT is a COVID-19 vaccine candidate developed by Beijing Wantai Biological, Xiamen University and the University of Hong Kong.[1][2][3]

On 14 December 2022, the vaccine was listed by the National Health Commission of China as a secondary booster dose option for people who have completed their third doses of inactivated COVID-19 vaccines for 6 months or longer.[4]

References

Шаблон:Reflist

Шаблон:Scholia

Шаблон:Vaccines Шаблон:COVID-19 pandemic Шаблон:Portal bar

Шаблон:COVID19-vaccine-stub Шаблон:Vaccine-stub